Beyond antibodies: new affinity reagents to unlock the proteome
- PMID: 24395722
- DOI: 10.1002/pmic.201300187
Beyond antibodies: new affinity reagents to unlock the proteome
Abstract
Antibodies have been the workhorse reagents of protein capture and quantification since their 1959 debut in the RIAs developed by Yalow and Berson. However, there are technical challenges to the use of antibodies in highly multiplexed arrays aimed at measuring hundreds or even thousands of proteins at one time. We describe here a recently developed class of synthetic protein-binding reagents (slow off-rate modified aptamer). We discuss the chemical makeup and protein binding specifications of slow off-rate modified aptamer reagents, compare them to traditional aptamers and antibodies, briefly describe the novel proteomic assay that takes advantage of their unique properties, and provide several examples of their multiple applications to biomarker discovery and validation across a range of biomedical science questions.
Keywords: Aptamer; Biomarker; Protein arrays; SOMAmer; SOMAscan.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
High-content affinity-based proteomics: unlocking protein biomarker discovery.Expert Rev Mol Diagn. 2010 Nov;10(8):1013-22. doi: 10.1586/erm.10.89. Expert Rev Mol Diagn. 2010. PMID: 21080818 Review.
-
Affinity proteomics: the role of specific binding reagents in human proteome analysis.Expert Rev Proteomics. 2012 Aug;9(4):401-14. doi: 10.1586/epr.12.34. Expert Rev Proteomics. 2012. PMID: 22967077 Review.
-
Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the Proteome.J Proteome Res. 2024 Nov 1;23(11):4771-4788. doi: 10.1021/acs.jproteome.4c00411. Epub 2024 Jul 22. J Proteome Res. 2024. PMID: 39038188 Free PMC article. Review.
-
Systematic antibody and antigen-based proteomic profiling with microarrays.Expert Rev Mol Diagn. 2011 Mar;11(2):219-34. doi: 10.1586/erm.10.110. Expert Rev Mol Diagn. 2011. PMID: 21405972 Review.
-
[Aptamers as perspective affine reagents for clinical proteomics].Biomed Khim. 2007 Jan-Feb;53(1):5-24. Biomed Khim. 2007. PMID: 17436681 Review. Russian.
Cited by
-
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease.Diabetologia. 2016 Sep;59(9):1819-31. doi: 10.1007/s00125-016-4001-9. Epub 2016 Jun 25. Diabetologia. 2016. PMID: 27344310 Free PMC article. Review.
-
Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers?Curr Rheumatol Rep. 2018 Jul 14;20(9):53. doi: 10.1007/s11926-018-0762-0. Curr Rheumatol Rep. 2018. PMID: 30008153 Review.
-
Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.Theranostics. 2019 Aug 22;9(22):6601-6617. doi: 10.7150/thno.37549. eCollection 2019. Theranostics. 2019. PMID: 31588238 Free PMC article.
-
Intraoperative plasma proteomic changes in cardiac surgery: In search of biomarkers of post-operative delirium.Proteomics Clin Appl. 2023 Jul;17(4):e2200066. doi: 10.1002/prca.202200066. Epub 2023 Jan 4. Proteomics Clin Appl. 2023. PMID: 36567636 Free PMC article.
-
Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma.Front Oncol. 2019 Nov 1;9:1150. doi: 10.3389/fonc.2019.01150. eCollection 2019. Front Oncol. 2019. PMID: 31737572 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources